Market View 12th September 2023

View on market: Volatility Prevails, Market is searching for better value

After Wall Street gained ground ahead of crucial American data that would likely reveal how close the Federal Reserve is to stopping its rate hikes, Asian stocks are expected to open mixed. While Australian markets are expected to open flat and Hong Kong may decline, futures in Japan indicated to gains. With the Nasdaq 100 up 1.2%, tech stocks were the main drivers of growth in the US. As Morgan Stanley predicted that the Dojo supercomputer may increase in worth by much to $500 billion, Tesla Inc. saw a 10% increase. After Apple Inc. extended a contract with the chipmaker, Qualcomm Inc. rose. WTI Crude prices were above the $87 level, and Brent Crude prices remained stable at $90 per barrel. The yield on the 10-year U.S. bond was trading at 4.29% and Bitcoin was below 26,000-level. At 5:23 a.m., the GIFT Nifty, an early indicator of the Nifty 50 Index’s performance in India was up 273 points or 1.37% at 20,135.5.

Economic Calendar:

• USD : CPI (MoM) (Aug) on 13^th Sep, 2023
• USD : PPI (MoM) (Aug) on 14^th Sep, 2023
• INR : CPI (YoY) (Aug) on 12^th Sep, 2023
• INR : Industrial Production (YoY) (Jul) on 12^th Sep, 2023

Brokerage Radar:

BERNSTEIN ON ZOMATO: Outperform Rating; Target Raised To Rs 120; Continues To Raise Profitability Bar With Break-even 3 Quarters Ahead Of Target; Strong Execution & Profit Has Reinforced Investor Confidence; Stock Has Graduated From ‘GMV Multiple’ To ‘Profit Multiple’; Medium-term EV/EBITDA Multiple Look Reasonable

NOMURA ON HUL: BUY, TP Rs 2950; 2Q24F: Anemic demand; GPM to improve but OPM muted; Weak 2Q expected as demand remains unchanged with ltd. signs of improvement; significant step up in A&P to drag down EBITDA growth; 2Q demand trends: Vol growth in low single-digits y-y

CLSA ON CEMENT: Strength in demand continued in July & Aug; There has been an unseasonal price increase in Sept.  However, that is partly offset by a sharp jump in fuel costs; As such, don’t see a case for upward revision in earnings yet while val remains elevated

International Markets

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DIIs:

News Update:

Reliance Industries: KKR will invest Rs 2,069.5 crore in the company’s subsidiary, Reliance Retail Ventures, increasing its stake to 1.42% from 1.17%. The deal values the retail giant at Rs 8.36 lakh crore.

ICICI Bank: The private lender has received the RBI’s nod for the re-appointment of Sandeep Bakhshi as MD and CEO for three years with effect from Oct. 4.

NTPC: Subsidiary NTPC Green Energy, signed an MoU with Nayara Energy to explore opportunities in the green hydrogen and green energy space for captive usage.

Larsen & Toubro: The company has increased the buyback price to Rs 3,200 from Rs 3,000 apiece, while the number of shares has been reduced from 3.33 crore to 3.12 crore.

Power Grid Corp: The company won the bid for a 20 GW inter-state transmission project in Rajasthan on a build, own, operate, and transfer (BOOT) basis.

Lupin: The drugmaker plans to enter into a business transfer agreement with subsidiary Lupin Manufacturing Solutions to carve out two active pharmaceutical ingredient manufacturing sites at Dabhasa and Visakhapatnam and select R&D operations, including fermentation, at Lupin Research Park, Pune. The consideration expected to be received is Rs 750–850 crore, and the deal is likely to be entered into in October 2023.

Torrent Power: In a clarification on media reports, the company said it has received confirmation from the members of the promoter group that no plans to create any pledge over the promoter’s shares in the company are under consideration.

Krishna Institute of Medical Sciences: Subsidiary KIMS Hospital Enterprise has acquired a further equity stake of 13.24% in Kondapur Healthcare for Rs 20 crore. The total stake now stands at 19.86%.

Laurus Labs: The company signed a share purchase agreement with a promoter and other shareholders of Laurus Bio for 37,641 equity shares through secondary purchase for Rs 71.6 crore. With this acquisition, the company’s shareholding in Laurus Bio will become 87.58% on a fully diluted basis.

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.